Finzati - Logo
DNLI logo

Denali Therapeutics Inc.

DNLI • Biotechnology
$22.28
▼ -0.52 (-2.28%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$3.92B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 145.1%Manageable debt level · 0.04Healthy liquidity · 9.16Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:39 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$22.28
Change-2.28%
Market Cap$3.92B
52W Range12.58 - 27.30
Beta1.00
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.04
Current Ratio9.16
Quick Ratio9.16
Target$34.57

Investment DNA

How strong this company looks for long-term investors

53
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
80/100
Why this score▼
Positive revenue growth · 145.1%Manageable debt level · 0.04Healthy liquidity · 9.16Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-12
Low
$26.00
Mean
$34.57
Median
$34.00
High
$41.00

Company Overview

IPO: 12/8/2017
Industry: Biotechnology
P/B i: 2.86
Debt / Equity i: 0.04
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.04
Current Ratio: 9.16
Quick Ratio: 9.16
Status: Good

Insider Transactions

Recent executive and insider activity

BAKER BROS. ADVISORS LP
Transaction: 06/03/2026
BUY
Change
+19,226
Price
$19.66
Filing
06/05/2026
Type
BUY
BAKER BROS. ADVISORS LP
Transaction: 06/03/2026
BUY
Change
+19,226
Price
$19.66
Filing
06/05/2026
Type
BUY
BAKER BROS. ADVISORS LP
Transaction: 06/03/2026
BUY
Change
+6,408
Price
Not reported
Filing
06/05/2026
Type
BUY